Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

Published Date: 16 Aug 2023

Most cancer deaths result from the metastatic spread and expansion of tumor cells at distant sites. Because there are few biomarkers and detection methods, it is difficult to determine the best treatments for patients with metastatic disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In NPM1-mutated acute myeloid leukemia, MRD Correlates with Allo-Transplant Benefit.

2.

Preoperative MRI is useful for identifying additional disease in breast cancer patients with nodes positive.

3.

When it comes to obesity-related cancers, where you shop for food matters

4.

Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.

5.

Cancer detection recovered following pandemic disruptions


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot